Assistance Publique - Hôpitaux de Paris: Pulmonary Fibrosis trials
The registry lists 12 Pulmonary Fibrosis studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 2 2Phase 3 4No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Influence of Socioeconomic and Environmental Factors on the Natural History of Idiopathic Pulmonary FibrosisRecruitingNCT04619199Not applicable
- Nintedanib for the Treatment of SARS-Cov-2 Induced Pulmonary FibrosisRecruitingNCT04541680Phase 3
- Digital Modeling of Thoracic CT and Pulmonary FibrosisActive, not recruitingNCT06618924
- Evolution of Lung 18FDG Uptake in Patients With Idiopathic Pulmonary Fibrosis and Receiving PirfenidoneStatus unknownNCT03692481Not applicable
- Lung Cancer and Idiopathic Pulmonary Fibrosis : Pathological and Molecular CharacterizationStatus unknownNCT03486262
- Pilot Study of Pirfenidone in Pulmonary Fibrosis With Anti-myeloperoxydase AntibodiesCompletedNCT03385668Phase 2
- Impact of a Systematic Palliative Care on Quality of Life, in Advanced Idiopathic Pulmonary Fibrosis.Status unknownNCT03229343Not applicable
- MRI Quantification of Pulmonary Fibrosis in Scleroderma PatientsCompletedNCT03207997Not applicable
- Cyclophosphamide for Acute Exacerbation of Idiopathic Pulmonary FibrosisCompletedNCT02460588Phase 3
- Conducting Airways in Lung Fibrosis (VACFI)CompletedNCT01777373
- Rituximab in Systemic SclerosisCompletedNCT01748084Phase 2/3
- Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung DiseaseCompletedNCT01570764Phase 3